Since nonfunctioning pancreatic NET's also occur from a young age, MEN1 testing should perhaps not only be limited to patients with insulinomas before the age of 20, but recommended for all patients with pancreatic NET's before this age. The gene discussed is MEN1; the disease is pancreatic neuroendocrine tumor.